Exploratory clinical trials: A non-clinical drug safety perspective

被引：0
|
作者：
Weaver, R. J. [1 ]
机构：
[1] Biol Servier, Gidy, France
来源：
TOXICOLOGY LETTERS | 2011年 / 205卷
关键词：
D O I：
10.1016/j.toxlet.2011.05.1048
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [31] Differentiating 'clinical' and 'non-clinical' depression
    Parker, G.
    Paterson, A.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2015, 131 (06) : 401 - 407
  • [32] CLINICAL AND NON-CLINICAL PROGRAMS IN WORKPLACE
    TRICE, HM
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1977, 19 (04) : 292 - 292
  • [33] Regulatory science for the safety evaluation to risk assessment/management in non-clinical drug research and development
    Horii, Ikuo
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 52P - 52P
  • [34] Assessing the fidelity of translation of non-clinical assays: a Pharma perspective
    Gintant, Gary
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (11) : 2564 - 2576
  • [35] Non-Clinical Development of Fixed CombinationsA European Regulatory Perspective
    Ulla Liminga
    Beatriz Silva Lima
    [J]. International Journal of Pharmaceutical Medicine, 2004, 18 (3) : 135 - 138
  • [36] IL-23 Antibodies in Psoriasis - a Non-Clinical Perspective
    Zhou, L.
    Wang, Y.
    Wan, Q.
    Perron, D.
    Zhu, R.
    Wang, L.
    Gauld, S.
    Veldman, T.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S282 - S282
  • [37] Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan
    Hebar, Alexandra
    Koller, Christiane
    Seifert, Jan-Marcus
    Chabicovsky, Monika
    Bodenteich, Angelika
    Bernkop-Schnuerch, Andreas
    Grassauer, Andreas
    Prieschl-Grassauer, Eva
    [J]. PLOS ONE, 2015, 10 (04):
  • [38] Non-clinical Safety Assessment of Angiotensin 1-7
    Thun, S.
    Petersen, K. U.
    Christoph, T.
    Schmitz, U.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S79 - S79
  • [39] Designing non-clinical safety evaluation programmes: The view of the clinician
    Lipani, J
    [J]. SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 1 - 6
  • [40] Non-clinical safety studies on biosimilar recombinant human erythropoietin
    Parnham, Michael J.
    Schindler-Horvat, Janice
    Kozlovic, Marija
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 100 (02) : 73 - 83
12345